Home > Financial Ratios > BAFNA PHARMACEUTICALS

BAFNA PHARMACEUTICALS
Core EBITDA Growth

    Back to All Ratios
AD     Remove this Ad

BAFNA PHARMACEUTICALS Last 5 Year Core EBITDA Growth History

[Standalone]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Growth(%) -4.88-22.9339.0023.66644.34

What is the latest Core EBITDA Growth ratio of BAFNA PHARMACEUTICALS ?

The latest Core EBITDA Growth ratio of BAFNA PHARMACEUTICALS is -4.88 based on Mar2025 Standalone results.
Year Core EBITDA Growth
Mar2025-4.88
Mar2024-22.93
Mar202339.00
Mar202223.66
Mar2021644.34

How is Core EBITDA Growth of BAFNA PHARMACEUTICALS Trending?

Years Core EBITDA Growth % Change
Mar2025 -4.88
Negative
Mar2024 -22.93
Negative
Mar2023 39
64.84
Mar2022 23.66
-96.33
Mar2021 644.34 -

Other Financial Ratios of BAFNA PHARMACEUTICALS


Compare Core EBITDA Growth ratio of peers of BAFNA PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BAFNA PHARMACEUTICALS ₹267.7 Cr -0.6% -2.6% 43.2% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹420,555.0 Cr -1.5% 1.6% 1.3% Stock Analytics
DIVIS LABORATORIES ₹159,889.0 Cr -2% -4.3% 3.3% Stock Analytics
TORRENT PHARMACEUTICALS ₹144,073.0 Cr -0.8% 0.5% 32% Stock Analytics
DR REDDYS LABORATORIES ₹105,133.0 Cr -2.7% -1.6% 6.9% Stock Analytics
CIPLA ₹98,492.9 Cr -3.9% -9.1% -18.4% Stock Analytics


BAFNA PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
BAFNA PHARMACEUTICALS

-0.6%

-2.6%

43.2%

SENSEX

-2.6%

-10.2%

-1.6%


You may also like the below Video Courses